Cargando…
Optimal Radiation Dose for Stage III Lung Cancer—Should “Definitive” Radiation Doses Be Used in the Preoperative Setting?
INTRODUCTION: There are currently two recommended radiation strategies for clinical stage III NSCLC: a lower “preoperative” (45–54 Gy) and a higher “definitive/nonsurgical” (60–70 Gy) dose. We sought to determine if definitive radiation doses should be used in the preoperative setting given that man...
Autores principales: | Saffarzadeh, Areo G., Canavan, Maureen, Resio, Benjamin J., Walters, Samantha L., Flores, Kaitlin M., Decker, Roy H., Boffa, Daniel J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8474436/ https://www.ncbi.nlm.nih.gov/pubmed/34590044 http://dx.doi.org/10.1016/j.jtocrr.2021.100201 |
Ejemplares similares
-
Radiation Dose to the Rectum With Definitive Radiation Therapy and Hydrogel Spacer Versus Postprostatectomy Radiation Therapy
por: Yang, Daniel X., et al.
Publicado: (2020) -
Immunotherapy After Chemotherapy and Radiation for Clinical Stage III Lung Cancer
por: Pichert, Matthew D., et al.
Publicado: (2022) -
Outcomes of surgically managed primary lung sarcomas: a National Cancer Database analysis
por: Li, Andrew X., et al.
Publicado: (2021) -
Dose-Response Relationship between Radiation Dose and Loco-regional Control in Patients with Stage II-III Esophageal Cancer Treated with Definitive Chemoradiotherapy
por: Kim, Hyun Ju, et al.
Publicado: (2017) -
Definitive, Preoperative, and Palliative Radiation Therapy of Esophageal Cancer
por: Fokas, Emmanouil, et al.
Publicado: (2015)